Skip to main content

Table 2 Overall resistance rate of Klebsiella pneumoniae to various antimicrobials

From: Klebsiella pneumoniae: an increasing threat to public health

SubgroupsNo. of events/studiesPrevalence of drug resistance, % (CI)Heterogeneity test
I2 (%)p value
Overall resistant to amikacin1140.8 (31.9–50.4)93.7< 0.001
Overall resistant to aztreonam973.3 (59.9–83.4)97.4< 0.001
Overall resistant to ceftazidime1075.7 (65.4–83.6)90.5< 0.001
Overall resistant to ciprpfloxacin1159.8 (48.6–70.1)96.4< 0.001
Overall resistant to colistin52.9 (1.8–4.4)0.00.5250
Overall resistant to cefotaxime879.2 (68.0–87.2)93.8< 0.001
Overall resistant to cefepime872.6 (57.7–83.8)96.9< 0.001
Overall resistant to gentamicin958 (49.2–66.3)89.7< 0.001
Overall resistant to imipenem1065.6 (30.8–89.0)99.6< 0.001
Overall resistant to levofloxacin654.1 (36.0–71.2)92.7< 0.001
Overall resistant to meropenem1162.7 (31.1–86.2)99.5< 0.001
Overall resistant to trimethoprim_sulfamethoxazole758.2 (35.5–77.9)98.8< 0.001
  1. CI, confidence interval; n, number of events (drug resistance); N, total number of Klebsiella pneumoniae from the included studies